Wj. Gillespie et al., DEVELOPMENT OF HEMATOPOIETIC CANCERS AFTER IMPLANTATION OF TOTAL JOINT REPLACEMENT, Clinical orthopaedics and related research, (329), 1996, pp. 290-296
The evidence from the 4 epidemiologic studies published before mid 199
5, which have investigated the incidence of cancers in patients who ha
ve undergone joint implants, is conflicting, The results of the 2 earl
ier studies suggested a sustained increase in the risk of lymphoma and
leukemia after total hip arthro- plasty, The results of the 2 more re
cent studies have not confirmed this, although in 1 study an increased
risk was observed in the first year after implantation. The heterogen
eity may be statistical in origin, but could also have a biologic expl
anation in the greater proportion of metal on metal prostheses used be
fore 1973. All 4 studies used national data as the comparison, Here ar
e presented the results of 2 matched cohort studies and a case control
study set in North America and Scotland, and an overview of the 4 pre
vious studies. Neither the results of the matched studies of patients
operated on after 1973 nor the results of the latter 2 published studi
es suggest an increased risk of lymphoma or leukemia. If metal on meta
l articulations are reintroduced, cartful surveillance is essential.